DBV Technologies | DBVT - Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amarin USD 126.83M 477K 2025-12
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
DBV Technologies USD 15.1M 1.05M 2026-03
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Incyte USD 1.13B 73.7M 2026-06
Insmed USD 215.32M 36.77M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Neurocrine Biosciences USD 887M 118.9M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 310.3M 1.7M 2026-06